MS
Therapeutic Areas
Synthaverse Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ONKO BCG ® 50 | Oncological Immunotherapy (Bladder Cancer) | Approved |
| ONKO BCG ® 100 | Oncological Immunotherapy (Bladder Cancer) | Approved |
| GAMMA ANTY-D ® 50 | Immunotherapy in Serological Conflict (RhD prophylaxis) | Approved |
| GAMMA ANTY-D ® 150 | Immunotherapy in Serological Conflict (RhD prophylaxis) | Approved |
| GAMMA ® ANTY HBS 200 | Passive Immunotherapy in Hepatitis B | Approved |
| BCG10 | Active Anti-Tuberculosis Immunoprophylaxis | Approved |
| Distreptaza ® | Gynecology and Proctology | Approved |
| LACTOBACILLUS / LAKCID ® | Probiotics | Approved |